Company Acasti Pharma Inc. Toronto S.E.
Equities
ACST
CA00430K8730
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 31/07/21 |
Director of Finance/CFO | 52 | 01-04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 07/05/23 |
Robert Macdonald
CTO | Chief Tech/Sci/R&D Officer | 62 | 07/05/23 |
Amresh Kumar
PRN | Corporate Officer/Principal | 44 | 14/05/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 09/10/23 |
Director/Board Member | - | 09/10/23 | |
Santosh Kottayil
BRD | Director/Board Member | 60 | 09/10/23 |
Chairman | 55 | 26/08/21 | |
Prashant Kohli
CEO | Chief Executive Officer | 52 | 31/07/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,399,404 | 7,893,546 ( 83.98 %) | 0 | 83.98 % |
Company contact information
![address Acasti Pharma Inc.(ACST)](https://cdn.zonebourse.com/static/address/24543223.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |